FinlandFinland

Brakes slam on VC investment

19.09.2009

Helsinki – According to a new survey, Finnish high-tech growth companies raised almost a51m in the first half of 2009, 17% down on the first half of 2008. Second quarter funding decreased by more than 50% from the same period in 2008.
Carried out by international valuation practitioner Technopolis, the survey reviewed capital raised by private Finnish high-tech companies from venture capital funds and from angel investors, both Finnish and foreign. It drew on both public and undisclosed information from 140 Finnish and foreign investors, and 1,500 Finnish high-tech firms, including ones from the software and ICT hardware sectors, nano­technology and the life sciences.
The authors say the study shows the clear impact of the global slowdown in venture capital. “More than 50 companies are seeking to raise funds right now in the Finnish market. We hope that the environment will improve in the second half of the year,” said Will Carwell, CEO of Technopolis Ventures.
Out of all the funds raised in the first half of 2009 by 29 companies, around EUR16m were attracted by the life sciences sector. Overall, the funds came from both domestic (EUR24.5m) and foreign (EUR22m) venture investors. According to the study, the average investment per company was EUR1.8m. 27 investment rounds were closed by seed and early stage companies, and no exits occurred.

FinlandFinland

11.02.2011

Helsinki – Using laser light to destroy tumour cells lodged in lymphatic vessels can halt the spread of cancer, Finnish researchers headed by Tuomas Tammela have demonstrated. Their approach to destroy the tumour cells, which use...

FinlandFinland

03.11.2010

Turku/Freiburg – EU researchers led by scientists at the University of Turku have begun designing a bacterium able to produce liquefied petroleum gas (LPG) from sunlight. “We have all the parts to put the ability for production...

FinlandFinland

19.09.2010

Rajamäki/Darmstadt – A cooperation project between AB Enzymes Oy and Royal Oy has resulted in the discovery of an enzyme that enables washing temperature to be dropped to as low as 10° C. The project is being funded by the SymBio...

FinlandFinland

08.07.2010

Turku – Finland’s Faron Pharmaceuticals Ltd. has announced a cooperation with German biotech company Priaxon AG to create new scaffold structures to modify the AOC3-protein function and its ligand interaction with orally...

FinlandFinland

09.06.2010

Tampere – Short people are at greater risk of developing heart disease than tall people, according to a meta-analysis of 52 populations-based studies including 3 million people by Finnish researchers (Eur. Heart J.,...

FinlandFinland

12.05.2010

Reykjavik – Researchers from the Icelandic bio­tech company deCODE – together with colleagues from 23 institutions in a dozen countries – have determined that genetic factors influence both nico­tine dependence and the incidence...

FinlandFinland

11.05.2010

Turku – Finnish Biotie Therapies Corp. confirmed that its oral phospho­diesterase 4 inhibitor ELB353 has proven safe and pharmacologically active in a Phase I study. Pharmacokinetic data point to the suitability of ELB353 for a...

FinlandFinland

07.03.2010

Helsinki/Hinxton – Finland has pledged EUR1.85m to help create world-class bio­informatics, biobanking and translational research infrastructures, the European Bioinformatics Institute (EBI) at the European Molecular Laboratory...

FinlandFinland

04.02.2010

Helsinki –Finland is investing EUR1.9m in creating world class bioinformatics, biobanking and translational research infrastructures. The investment comes as part of the linkage of three large EU projects ELIXIR, BBMRI, and...

Displaying results 11 to 20 out of 96

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-finland/browse/1/article/brakes-slam-on-vc-investment.html

Print Magazine

Event Video

All videos

Events

All Events

Stock list

All quotes

TOP

  • EPIGENOMICS4.34 EUR11.57%
  • PAION2.86 EUR10.85%
  • STRATEC BIOMEDICAL41.92 EUR3.92%

FLOP

  • CYTOS0.15 CHF-6.25%
  • MAGFORCE5.40 EUR-6.09%
  • CO.DON2.70 EUR-5.26%

TOP

  • BIOFRONTERA2.84 EUR29.1%
  • EPIGENOMICS4.34 EUR13.3%
  • VITA 344.42 EUR7.5%

FLOP

  • MAGFORCE5.40 EUR-21.7%
  • CYTOS0.15 CHF-16.7%
  • CO.DON2.70 EUR-14.0%

TOP

  • SANTHERA89.00 CHF2318.5%
  • CO.DON2.70 EUR172.7%
  • PAION2.86 EUR83.3%

FLOP

  • CYTOS0.15 CHF-96.2%
  • THERAMETRICS0.07 CHF-46.2%
  • 4SC0.94 EUR-43.4%

No liability assumed, Date: 30.10.2014


Current issue

All issues

Product of the week

Products